Data di Pubblicazione:
2009
Citazione:
Doxorubicin and congo red effectiveness on prion infectivity in golden Syrian hamster / M. Corato, P. Ogliari, F. Ceciliani, E. Cova, V. Bellotti, C. Cereda, G. Merlini, M. Ceroni. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 29:7(2009 Jul), pp. 2507-2512.
Abstract:
The effect of doxorubicin and Congo Red on prion protein (PrP) infectivity in experimental scrapie was studied to better understand the effect of these compounds in prion diseases and to establish whether a dose-response correlation exists for Congo Red. This was performed in order to test the effectiveness of compounds that may easily be used in human prion diseases. Brain homogenate containing membrane bound PrPSc monomers was used as inoculum and was previously incubated with doxorubicin 10(-3) M and with increasing concentrations of Congo Red ranging from 10(-7) to 10(-2) M. This study shows for the first time that doxorubicin, and confirms that Congo Red, may interact with pathological PrP monomers modifying their infectious properties. Pre-incubation of infected brain homogenate with Congo Red resulted in prolonged incubation time and survival, independently of Congo Red concentration (p<0.05). Doxorubicin and Congo Red effects do not depend upon interaction with PrP amyloid material.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Amyloid plaques; Congo Red; Doxorubicin; Prion disease
Elenco autori:
M. Corato, P. Ogliari, F. Ceciliani, E. Cova, V. Bellotti, C. Cereda, G. Merlini, M. Ceroni
Link alla scheda completa:
Link al Full Text: